During their occupational activities in space, astronauts are exposed to ionising radiation from natural radiation sources present in this environment. They are, however, not usually classified as being occupationally exposed in the sense of the general ICRP system for radiation protection of workers applied on Earth. The exposure assessment and risk-related approach described in this report is clearly restricted to the special situation in space, and should not be applied to any other exposure situation on Earth. The report describes the terms and methods used to assess the radiation exposure of astronauts, and provides data for the assessment of organ doses. Chapter 1 describes the specific situation of astronauts in space, and the differences in the radiation fields compared with those on Earth. In Chapter 2, the radiation fields in space are described in detail, including galactic cosmic radiation, radiation from the Sun and its special solar particle events, and the radiation belts surrounding the Earth. Chapter 3 deals with the quantities used in radiological protection, describing the Publication 103 (ICRP, 2007) system of dose quantities, and subsequently presenting the special approach for applications in space; due to the strong contribution of heavy ions in the radiation field, radiation weighting is based on the radiation quality factor, Q, instead of the radiation weighting factor, wR. In Chapter 4, the methods of fluence and dose measurement in space are described, including instrumentation for fluence measurements, radiation spectrometry, and area and individual monitoring. The use of biomarkers for the assessment of mission doses is also described. The methods of determining quantities describing the radiation fields within a spacecraft are given in Chapter 5. Radiation transport calculations are the most important tool. Some physical data used in radiation transport codes are presented, and the various codes used for calculations in high-energy radiation fields in space are described. Results of calculations and measurements of radiation fields in spacecraft are given. Some data for shielding possibilities are also presented. Chapter 6 addresses methods of determining mean absorbed doses and dose equivalents in organs and tissues of the human body. Calculated conversion coefficients of fluence to mean absorbed dose in an organ or tissue are given for heavy ions up to Z=28 for energies from 10 MeV/u to 100 GeV/u. For the same set of ions and ion energies, mean quality factors in organs and tissues are presented using, on the one hand, the Q(L) function defined in Publication 60 (ICRP, 1991), and, on the other hand, a Q function proposed by the National Aeronautics and Space Administration. Doses in the body obtained by measurements are compared with results from calculations, and biodosimetric measurements for the assessment of mission doses are also presented. In Chapter 7, operational measures are considered for assessment of the exposure of astronauts during space missions. This includes prefli...
The International Commission on Radiological Protection (ICRP) has embarked on a review and revision of the system of Radiological Protection that will update the 2007 general recommendations in ICRP Publication 103. This is the beginning of a process that will take several years, involving open and transparent engagement with organisations and individuals around the world. While the system is robust and has performed well, it must adapt to address changes in science and society to remain fit for purpose. The aim of this paper is to encourage discussions on which areas of the system might gain the greatest benefit from review, and to initiate collaborative efforts. Increased clarity and consistency are high priorities. The better the system is understood, the more effectively it can be applied, resulting in improved protection and increased harmonisation. Many areas are identified for potential review including: classification of effects, with particular focus on tissue reactions; reformulation of detriment, potentially including non-cancer diseases; re-evaluation of the relationship between detriment and effective dose, and the possibility of defining detriments for males and females of different ages; individual variation in the response to radiation exposure; heritable effects; and effects and risks in non-human biota and ecosystems. Some of the basic concepts are also being considered, including the framework for bringing together protection of people and the environment, incremental improvements to the fundamental principles of justification and optimisation, a broader approach to protection of individuals, and clarification of the exposure situations introduced in 2007. In addition, ICRP is considering identifying where explicit incorporation of the ethical basis of the system would be beneficial, how to better reflect the importance of communications and stakeholder involvement, and further advice on education and training. ICRP invites responses on these and other areas relating to the review of the System of Radiological Protection.
NCRP Report No. 180, ‘Management of Exposure to Ionizing Radiation: Radiation Protection Guidance for the United States (2018)’ was developed by Council Committee 1. The report builds and expands upon previous recommendations of NCRP and ICRP, covering exposure to radiation and radioactive materials for five exposure categories: occupational, public, medical, emergency workers, and nonhuman biota. Actions to add, increase, reduce or remove a source of exposure to humans require justification. Optimisation of protection universally applies, taking into account societal, economic, and environmental factors; addressing all hazards, and striving for continuous improvement when it is reasonable to do so. Numeric protection criteria for management of dose to an individual for a given exposure situation are provided, and differ in some respects from ICRP. A specific numeric criterion is suitable to be designated as a regulatory dose limit only when the source of exposure is stable, characterised, and the responsible organisation has established an appropriate radiation control program in advance of source introduction. Medical exposure includes patients, comforters and caregivers of a patient, and voluntary participants in biomedical research. Emergency workers are a new exposure category; their exposure is treated separately from occupational, public or medical exposure, and numeric criteria are provided for deterministic and stochastic effects. For nonhuman biota, the focus is on population maintenance of the affected species, and a guideline is provided for when additional assessment may be necessary. In addition, the recommendations emphasise that: ethical principles support decision-making; stakeholder engagement is necessary in deciding suitable management of their radiation exposure; and a strong safety culture is intrinsic to effective radiation protection programs.
La Commission internationale de protection radiologique (CIPR) a initié un examen et une révision du système de radioprotection afin de mettre à jour les recommandations générales de 2007 dans la Publication 103 de la CIPR. Il s’agit du début d’un processus de plusieurs années qui nécessite une collaboration ouverte et transparente avec les organismes et les personnes du monde entier. Bien que le système soit robuste et efficace, il convient de l’adapter à l’évolution des connaissances scientifiques et de la société afin de demeurer adapté aux besoins. Le présent document vise à encourager les discussions sur les domaines du système qui pourraient bénéficier le plus d’un examen, et à engager des initiatives de collaboration. Le renforcement de la clarté et de la cohérence constitue une priorité. Plus le degré de compréhension du système est élevé, plus il est possible de l’appliquer efficacement, ce qui se traduit par une amélioration de la protection et une harmonisation accrue. De nombreux domaines pourraient faire l’objet d’un examen, notamment : la classification des effets, avec un accent particulier sur les réactions tissulaires ; la reformulation du détriment radiologique, qui pourrait inclure les maladies non cancéreuses ; la réévaluation de la relation entre le détriment et la dose efficace, et la possibilité de définir des détriments pour les hommes et les femmes et différentes classes d’âge ; la variation de la réponse individuelle à l’exposition aux rayonnements ; les effets héréditaires ; les effets et risques pour le biote non humain et les écosystèmes. Certains des concepts de base sont également examinés, notamment le cadre permettant de réunir la protection des personnes et de l’environnement, les améliorations progressives des principes fondamentaux de justification et d’optimisation, une approche plus large de la protection des personnes et la clarification des situations d’exposition introduites en 2007. En outre, la CIPR envisage de déterminer dans quels cas l’incorporation explicite des fondements éthiques dans le système présenterait un avantage, comment mieux refléter l’importance des échanges et de l’implication des parties prenantes, et de donner des conseils supplémentaires sur l’éducation et la formation. La CIPR invite à répondre à ces questions et à d’autres liées à l’examen du système de radioprotection.
This document presents the ICRP's updated vision on “Areas of Research to Support the System of Radiological Protection”, which have been previously published in 2017. It aims to complement the research priorities promoted by other relevant international organisations, with the specificity of placing them in the perspective of the evolution of the System of Radiological Protection. This document contributes to the process launched by ICRP to review and revise the System of Radiological Protection that will update the 2007 General Recommendations in ICRP Publication 103.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.